• Profile
Close

A clinical decision instrument to predict 30-day death & cardiovascular hospitalizations following an Emergency Department visit for atrial fibrillation: The atrial fibrillation in the emergency room, part 2 (AFTER2) study

American Heart Journal Jun 21, 2018

Atzema CL, et al. - In this retrospective cohort study, researchers aimed at proposing and validating a predictive tool for a composite of 30-day mortality and return cardiovascular hospitalizations for atrial fibrillation (AF) patients seen in the emergency department. They successfully derived and validated such a tool by using a population-based sample. The utility of this tool lies in its ability to provide information regarding the risk of death and re-hospitalization in this patient population. Furthermore, the tool can help identify patient groups for future targeted interventions focused on avoiding these outcomes.

Methods

  • This retrospective cohort study was conducted at 24 emergency departments in Ontario, Canada.
  • Participants were patients with a primary diagnosis of AF who were seen between April 2008 and March 2009.
  • Researchers evaluated a composite outcome of 30-day mortality and ensuing hospitalizations for a cardiovascular issue, including stroke.

Results

  • A total of 3,510 patients were included; 2,343 were randomly selected for the derivation cohort, leaving 1,167 in the validation cohort.
  • The incidence of the composite outcome was noted in 227 (9.7%) patients in the derivation cohort and 125 (10.7%) patients in the validation cohort.
  • Findings demonstrated an independent association of 11 variables with the outcome: older age, not taking anticoagulation, HAS-BLED score ≥ 3, three lab results (positive troponin, supratherapeutic INR, and elevated creatinine), emergency department administration of furosemide, and four patient comorbidities (heart failure, COPD, cancer, dementia).
  • They found that the observed 30-day outcomes in the five risk strata that were defined using the derivation cohort were 2.0%, 6.6%, 10.7%, 12.5% and 20.0% in the validation cohort.
  • In the derivation and validation cohort, the observed c-statistic was 0.73 and 0.69, respectively.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay